These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21445656)

  • 1. Alpha-tricalcium phosphate (α-TCP): solid state synthesis from different calcium precursors and the hydraulic reactivity.
    Cicek G; Aksoy EA; Durucan C; Hasirci N
    J Mater Sci Mater Med; 2011 Apr; 22(4):809-17. PubMed ID: 21445656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amorphous phases during the hydraulic conversion of α-TCP into calcium-deficient hydroxyapatite.
    Hurle K; Neubauer J; Bohner M; Doebelin N; Goetz-Neunhoeffer F
    Acta Biomater; 2014 Sep; 10(9):3931-41. PubMed ID: 24681375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the chemical composition of monetite on the synthesis and properties of α-tricalcium phosphate.
    Duncan J; Macdonald JF; Hanna JV; Shirosaki Y; Hayakawa S; Osaka A; Skakle JM; Gibson IR
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():123-9. PubMed ID: 24268241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of novel biphasic calcium phosphate powders (alpha-TCP/HA) derived from carbonated amorphous calcium phosphates.
    Li Y; Kong F; Weng W
    J Biomed Mater Res B Appl Biomater; 2009 May; 89(2):508-517. PubMed ID: 18937266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlating crystallinity and reactivity in an alpha-tricalcium phosphate.
    Camiré CL; Gbureck U; Hirsiger W; Bohner M
    Biomaterials; 2005 Jun; 26(16):2787-94. PubMed ID: 15603774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallized nano-sized alpha-tricalcium phosphate from amorphous calcium phosphate: microstructure, cementation and cell response.
    Vecbiskena L; Gross KA; Riekstina U; Yang TC
    Biomed Mater; 2015 Apr; 10(2):025009. PubMed ID: 25886478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization and mechanical performance of dense beta-TCP ceramics with/without magnesium substitution.
    Zhang X; Jiang F; Groth T; Vecchio KS
    J Mater Sci Mater Med; 2008 Sep; 19(9):3063-70. PubMed ID: 18392667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Mg(2+) doping on beta-alpha phase transition in tricalcium phosphate (TCP) bioceramics.
    Frasnelli M; Sglavo VM
    Acta Biomater; 2016 Mar; 33():283-9. PubMed ID: 26796207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the reactivity and in vitro bioactivity of Sr-substituted alpha-TCP cements.
    Saint-Jean SJ; Camiré CL; Nevsten P; Hansen S; Ginebra MP
    J Mater Sci Mater Med; 2005 Nov; 16(11):993-1001. PubMed ID: 16388381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-grinding significance for calcium carbonate-calcium phosphate mixed cement. Part I: effect of particle size and mixing on solid phase reactivity.
    Tadier S; Le Bolay N; Rey C; Combes C
    Acta Biomater; 2011 Apr; 7(4):1817-26. PubMed ID: 21147278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calorimetry investigations of milled α-tricalcium phosphate (α-TCP) powders to determine the formation enthalpies of α-TCP and X-ray amorphous tricalcium phosphate.
    Hurle K; Neubauer J; Bohner M; Doebelin N; Goetz-Neunhoeffer F
    Acta Biomater; 2015 Sep; 23():338-346. PubMed ID: 26026302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase development and sintering behaviour of biphasic HA-TCP calcium phosphate materials prepared from hydroxyapatite and bioactive glass.
    Behnamghader A; Bagheri N; Raissi B; Moztarzadeh F
    J Mater Sci Mater Med; 2008 Jan; 19(1):197-201. PubMed ID: 17597356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydration mechanism of partially amorphized β-tricalcium phosphate.
    Hurle K; Neubauer J; Goetz-Neunhoeffer F
    Acta Biomater; 2017 May; 54():429-440. PubMed ID: 28288934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(para-dioxanone)/inorganic particle composites as a novel biomaterial.
    Bai W; Chen D; Zhang Z; Li Q; Zhang D; Xiong C
    J Biomed Mater Res B Appl Biomater; 2009 Aug; 90(2):945-51. PubMed ID: 19360890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of magnesium doping on the phase transformation temperature of beta-TCP ceramics examined by Rietveld refinement.
    Enderle R; Götz-Neunhoeffer F; Göbbels M; Müller FA; Greil P
    Biomaterials; 2005 Jun; 26(17):3379-84. PubMed ID: 15621226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sintering of biphasic calcium phosphates.
    Brown O; McAfee M; Clarke S; Buchanan F
    J Mater Sci Mater Med; 2010 Aug; 21(8):2271-9. PubMed ID: 20232235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel highly biodegradable biphasic tricalcium phosphates composed of alpha-tricalcium phosphate and beta-tricalcium phosphate.
    Li Y; Weng W; Tam KC
    Acta Biomater; 2007 Mar; 3(2):251-4. PubMed ID: 16979393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How calcite and modified hydroxyapatite influence physicochemical properties and cytocompatibility of alpha-TCP based bone cements.
    Zima A; Czechowska J; Siek D; Olkowski R; Noga M; Lewandowska-Szumieł M; Ślósarczyk A
    J Mater Sci Mater Med; 2017 Aug; 28(8):117. PubMed ID: 28681217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the calcium to phosphorus ratio on the setting properties of calcium phosphate bone cements.
    Vlad MD; Gómez S; Barracó M; López J; Fernández E
    J Mater Sci Mater Med; 2012 Sep; 23(9):2081-90. PubMed ID: 22639154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The properties of sintered calcium phosphate with [Ca]/[P] = 1.50.
    Hung IM; Shih WJ; Hon MH; Wang MC
    Int J Mol Sci; 2012 Oct; 13(10):13569-86. PubMed ID: 23202968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.